www.amphionplc.com
Amphion builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK.
Amphion has a significant shareholding in 8 Partner Companies developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million.
Amphion Innovations plc Partner Company, DataTern, Signs Four License Agreements worth $1.8 million
London and New York, 25 June 2009 – Amphion Innovations plc (LSE: AMP) (“Amphion”), the developer of medical and technology businesses, today announces that its wholly owned subsidiary DataTern, Inc., has signed additional non-exclusive intellectual property license agreements with four leading international corporations for a total of $1.8 million. DataTern has signed eleven licenses since it commenced licensing of this product in June 2008, generating total revenues of approximately $8.8 million. DataTern has now licensed its intellectual property into the financial, credit card, retail, leisure, healthcare, airline, e-commerce, and software industries.
DataTern, Inc., was established in order to commercialise selected intellectual property opportunities in partnership with Amphion’s Partner Companies.
Joseph Flicek, DataTern’s Chief Executive Officer, said: “We are pleased to announce these four additional license agreements, which we believe reflect the strength and breadth of DataTern’s technologies. We are currently in discussions with over 15 additional organisations about licensing our products and look forward to announcing further licensees in the second half of the year.”
Richard Morgan, Chief Executive Officer of Amphion, said: “We were pleased to see DataTern’s intellectual property licensing programme get back on track in May and with these four new license agreements we have surpassed our plan for the first half year. Amphion’s eight Partner Companies are all built on innovative and important intellectual property foundations and between them they own or control over 200 separately identified pieces of intellectual property. This represents a rich reservoir of opportunity to replicate the success of our first programme and build on the expertise we have developed in this field.”
For further information please contact
Amphion Innovations plc
Charlie Morgan, Director of Communications
+1 (212) 210 6224
Cardew Group
Tim Robertson/ Jamie Milton/ Matthew Law
+44 20 7930 0777
Charles Stanley (Nominated Adviser)
Mark Taylor/ Freddy Crossley
+44 20 7149 6000
About Amphion Innovations plc
Amphion (LSE: AMP) builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 10 Partner Companies developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million.
On the web: www.amphionplc.com
About DataTern, Inc.
DataTern owns and develops critical technology that provides next generation software solutions for its customers. DataTern’s patented product offerings include ObjectSpark® Technologies, which allow customers to develop their own customised data service layers, making the company’s offerings valuable to most industries, including automotive, banking, chemical, communications, financial, government, healthcare, insurance, pharmaceutical, trading, and many others. Non-exclusive licenses for DataTern’s technologies and patents are available on reasonable and non-discriminatory terms.
For licensing terms, please contact info@datatern.com.
On the web: www.datatern.com
